Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Search
31 result(s) found, displaying 26 to 31
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Regulatory decision noticesLabelling exemption for COVID-19 Vaccine - Novavax.
-
Regulatory decision noticesA new Therapeutic Goods Determination for listed medicine ingredients commenced on 18 January 2022.
-
Regulatory decision noticesThis instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Treatment—Merck Sharp and Dohme) (Molnupiravir) Labelling Exemption 2022.
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.